George Bensch, MD
Allergy/Immunology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 58 years
- University of North Carolina at Chapel Hill School of Medicine, 1968
Offices
1 location · Allergy Immunology and Asthma Medical Group Inc · 4 clinicians in this group
Hospitals listed: Mark Twain Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bensch’s office at (209) 951-5353 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mark Twain Medical CenterSan Andreas, CACritical Access Hospital · Voluntary non-profit - Other · No emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Mark Twain Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 9.3 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.9 · 116 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 353 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 81.9 · 54 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33.7 · 108 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4 to 9.3) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (7.3 to 14.2) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.4) · 375 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 89 cases | No different | Jan 2024 – Dec 2024 |
What patients said (151 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 89% |
| Nurses "always" communicated well | 90% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 85% |
| Nurses "always" listened carefully | 91% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 60% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$685,172
Medicare paid this office $685,172 for 1,026 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Professional service for preparation and provision of 1 or more antigens | 666 | $210,153 | $11 |
| Professional service for multiple injections of allergen | 896 | $104,526 | $9 |
| Short return visit (20+ min) | 607 | $52,572 | $63 |
| Test for allergy using allergenic extract injected into skin | 136 | $23,139 | $6 |
| Test for allergy using allergenic extract | 149 | $22,777 | $3 |
See all 15 services
| Professional service for preparation and provision of 1 or more antigens | 666 | $210,153 | $11 |
| Professional service for multiple injections of allergen | 896 | $104,526 | $9 |
| Short return visit (20+ min) | 607 | $52,572 | $63 |
| Test for allergy using allergenic extract injected into skin | 136 | $23,139 | $6 |
| Test for allergy using allergenic extract | 149 | $22,777 | $3 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 335 | $14,664 | $30 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $8,835 | $57 |
| New patient visit (45+ min) | 70 | $8,337 | $119 |
| Short return visit | 20 | $5,211 | $42 |
| Return visit (30+ min) | 42 | $4,191 | $91 |
| Telephone medical discussion with physician, 5-10 minutes | 79 | $3,207 | $40 |
| Professional service for single injection of allergen | 32 | $2,203 | $8 |
| Test to measure expiratory airflow and volume | 80 | $1,650 | $20 |
| New patient visit (30+ min) | 15 | $1,273 | $85 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,223 | $58 |
Who their Medicare patients are
1,026 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 10% · Women 66% · Also on Medicaid 21% · Health risk score 0.99. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 75% · Diabetes 29% · Coronary heart disease 23% · Chronic kidney disease 21% · Depression 18% · COPD 17% · Atrial fibrillation 13% · Heart failure 12% · Cancer 12% · Stroke 5% · Dementia 3%.
The office billed $2,175,209, Medicare allowed $890,539 and paid $685,172; for 54,771 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,026 | 54,771 | 74 | 0.99 | $2,175,209 | $685,172 |
| 2023 | 951 | 59,440 | 74 | 0.98 | $2,381,908 | $808,905 |
| 2022 | 986 | 56,066 | 73 | 0.91 | $2,337,806 | $738,834 |
| 2021 | 1,067 | 62,434 | 73 | 0.92 | $2,408,026 | $747,162 |
| 2020 | 1,128 | 56,863 | 72 | 0.96 | $2,257,789 | $682,145 |
| 2019 | 904 | 53,130 | 72 | 1.02 | $2,122,106 | $620,355 |
| 2018 | 910 | 53,061 | 72 | 1.03 | $2,041,295 | $522,045 |
| 2017 | 940 | 55,269 | 72 | 1.05 | $2,066,122 | $566,456 |
| 2016 | 907 | 46,364 | 72 | 1.04 | $1,837,755 | $497,605 |
| 2015 | 818 | 39,189 | 72 | 1.00 | $1,589,725 | $412,694 |
| 2014 | 818 | 39,634 | 72 | 0.91 | $1,552,116 | $409,646 |
| 2013 | 837 | 42,638 | 72 | 0.94 | $1,646,661 | $463,088 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Professional service for preparation and provision of 1 or more antigens | 688 | $235,538 | $12 |
| Professional service for multiple injections of allergen | 779 | $101,702 | $9 |
| Short return visit (20+ min) | 654 | $54,877 | $63 |
| Test for allergy using allergenic extract | 171 | $30,880 | $3 |
| Test for allergy using allergenic extract injected into skin | 164 | $29,079 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 394 | $15,541 | $30 |
| New patient visit (45+ min) | 103 | $12,592 | $122 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 30 | $12,524 | $60 |
| Short return visit | 29 | $7,526 | $43 |
| Return visit (30+ min) | 34 | $3,357 | $96 |
| Test to measure expiratory airflow and volume | 127 | $2,821 | $21 |
| Telephone medical discussion with physician, 5-10 minutes | 65 | $2,766 | $40 |
| New patient visit (60+ min) | 16 | $2,661 | $166 |
| Professional service for single injection of allergen | 25 | $1,262 | $8 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $808 | $73 |
| Test to measure the level of nitric oxide gas | 21 | $287 | $14 |
2022: 18 services
| Professional service for preparation and provision of 1 or more antigens | 702 | $247,388 | $13 |
| Professional service for multiple injections of allergen | 807 | $109,029 | $8 |
| Short return visit (20+ min) | 632 | $55,218 | $63 |
| Test for allergy using allergenic extract | 177 | $33,702 | $3 |
| Test for allergy using allergenic extract injected into skin | 165 | $31,965 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 392 | $16,972 | $29 |
| New patient visit (45+ min) | 95 | $12,124 | $128 |
| Return visit (30+ min) | 68 | $6,228 | $85 |
| Short return visit | 23 | $6,143 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 102 | $3,988 | $38 |
| Test to measure the level of nitric oxide gas | 128 | $2,739 | $14 |
| New patient visit (60+ min) | 16 | $2,345 | $147 |
| Test to measure expiratory airflow and volume | 113 | $2,329 | $20 |
| New patient visit (30+ min) | 26 | $2,154 | $83 |
| Injection of drug or substance under skin or into muscle | 26 | $1,583 | $11 |
| Influenza vaccine split virus, preservative free | 26 | $1,529 | $59 |
| Professional service for single injection of allergen | 24 | $1,338 | $7 |
| Administration of influenza virus vaccine | 28 | $768 | $27 |
2021: 17 services
| Professional service for preparation and provision of 1 or more antigens | 749 | $268,500 | $13 |
| Professional service for multiple injections of allergen | 877 | $119,721 | $8 |
| Short return visit (20+ min) | 723 | $69,787 | $66 |
| Test for allergy using allergenic extract | 259 | $50,408 | $3 |
| Test for allergy using allergenic extract injected into skin | 242 | $49,425 | $7 |
| New patient visit (45+ min) | 137 | $16,630 | $121 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 287 | $14,887 | $37 |
| Test to measure expiratory airflow and volume | 366 | $10,085 | $23 |
| Return visit (30+ min) | 54 | $5,974 | $107 |
| Short return visit | 20 | $3,344 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 67 | $2,779 | $38 |
| New patient visit (30+ min) | 31 | $2,619 | $84 |
| Influenza vaccine split virus, preservative free | 36 | $2,160 | $60 |
| Professional service for single injection of allergen | 31 | $1,218 | $7 |
| Test to measure the level of nitric oxide gas | 49 | $856 | $17 |
| Injection of drug or substance under skin or into muscle | 13 | $784 | $12 |
| Administration of influenza virus vaccine | 39 | $695 | $18 |
2020: 18 services
| Professional service for preparation and provision of 1 or more antigens | 705 | $229,048 | $12 |
| Professional service for multiple injections of allergen | 962 | $109,666 | $8 |
| Short return visit (20+ min) | 704 | $55,542 | $55 |
| Test for allergy using allergenic extract | 228 | $44,173 | $3 |
| Test for allergy using allergenic extract injected into skin | 203 | $37,865 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 365 | $24,178 | $45 |
| New patient visit (45+ min) | 99 | $12,313 | $124 |
| Test to measure expiratory airflow and volume | 201 | $6,770 | $30 |
| Return visit (30+ min) | 41 | $3,684 | $86 |
| Influenza vaccine split virus, preservative free | 42 | $2,515 | $60 |
| Short return visit | 15 | $2,436 | $38 |
| New patient visit (30+ min) | 29 | $2,257 | $78 |
| New patient visit (60+ min) | 12 | $1,594 | $133 |
| Professional service for single injection of allergen | 23 | $1,221 | $7 |
| Test to measure the level of nitric oxide gas | 55 | $865 | $12 |
| Injection of drug or substance under skin or into muscle | 15 | $858 | $12 |
| Administration of influenza virus vaccine | 46 | $813 | $18 |
| Telephone medical discussion with physician, 5-10 minutes | 23 | $790 | $34 |
2019: 15 services
| Professional service for preparation and provision of 1 or more antigens | 664 | $209,361 | $12 |
| Professional service for multiple injections of allergen | 764 | $95,961 | $8 |
| Short return visit (20+ min) | 699 | $60,731 | $54 |
| Test for allergy using allergenic extract | 208 | $41,931 | $3 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 480 | $38,998 | $47 |
| Test for allergy using allergenic extract injected into skin | 198 | $37,279 | $7 |
| New patient visit (45+ min) | 97 | $10,929 | $113 |
| Return visit (30+ min) | 70 | $6,266 | $87 |
| Test to measure the level of nitric oxide gas | 254 | $6,237 | $16 |
| Test to measure expiratory airflow and volume | 84 | $2,743 | $28 |
| Influenza vaccine split virus, preservative free | 38 | $2,240 | $55 |
| New patient visit (60+ min) | 12 | $1,959 | $163 |
| New patient visit (30+ min) | 18 | $1,503 | $84 |
| Administration of influenza virus vaccine | 43 | $797 | $17 |
| Injection of drug or substance under skin or into muscle | 14 | $458 | $14 |
2018: 14 services
| Professional service for preparation and provision of 1 or more antigens | 638 | $175,208 | $10 |
| Professional service for multiple injections of allergen | 753 | $88,682 | $7 |
| Short return visit (20+ min) | 701 | $57,613 | $50 |
| Test for allergy using allergenic extract | 218 | $49,412 | $4 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 495 | $39,526 | $45 |
| Test for allergy using allergenic extract injected into skin | 206 | $38,606 | $6 |
| New patient visit (45+ min) | 117 | $13,300 | $114 |
| Return visit (30+ min) | 56 | $4,456 | $80 |
| Test to measure the level of nitric oxide gas | 121 | $3,010 | $15 |
| New patient visit (60+ min) | 18 | $2,653 | $147 |
| Influenza vaccine split virus, preservative free | 45 | $2,345 | $52 |
| Test to measure expiratory airflow and volume | 53 | $1,621 | $27 |
| New patient visit (30+ min) | 17 | $1,118 | $66 |
| Administration of influenza virus vaccine | 49 | $1,052 | $21 |
2017: 15 services
| Professional service for preparation and provision of 1 or more antigens | 650 | $178,019 | $10 |
| Professional service for multiple injections of allergen | 745 | $90,966 | $7 |
| Test for allergy using allergenic extract | 252 | $77,799 | $5 |
| Short return visit (20+ min) | 680 | $63,772 | $52 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 517 | $45,982 | $47 |
| Test for allergy using allergenic extract injected into skin | 265 | $45,543 | $6 |
| New patient visit (45+ min) | 169 | $19,664 | $116 |
| Return visit (30+ min) | 126 | $13,828 | $80 |
| New patient visit (60+ min) | 20 | $3,189 | $159 |
| Test to measure the level of nitric oxide gas | 112 | $2,556 | $16 |
| Influenza vaccine split virus, preservative free | 47 | $2,252 | $48 |
| Test to measure expiratory airflow and volume | 54 | $1,830 | $26 |
| Administration of influenza virus vaccine | 51 | $1,395 | $27 |
| Professional service for single injection of allergen | 16 | $1,193 | $6 |
| Short return visit | 17 | $543 | $32 |
2016: 17 services
| Professional service for preparation and provision of 1 or more antigens | 589 | $153,485 | $10 |
| Professional service for multiple injections of allergen | 720 | $88,158 | $8 |
| Short return visit (20+ min) | 656 | $60,574 | $52 |
| Test for allergy using allergenic extract | 172 | $55,996 | $5 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 457 | $40,532 | $47 |
| Test for allergy using allergenic extract injected into skin | 213 | $36,979 | $6 |
| New patient visit (45+ min) | 141 | $17,026 | $121 |
| Return visit (30+ min) | 114 | $13,034 | $82 |
| Injection for rapid desensitization to allergen | 13 | $12,667 | $101 |
| New patient visit (60+ min) | 29 | $4,236 | $146 |
| Professional service for preparation and provision of single-dose vial of allergen | 13 | $3,269 | $10 |
| Test to measure expiratory airflow and volume | 68 | $3,119 | $27 |
| Influenza vaccine split virus, preservative free | 33 | $1,344 | $41 |
| Professional service for single injection of allergen | 22 | $1,341 | $7 |
| Test to measure the level of nitric oxide gas | 54 | $1,114 | $15 |
| Administration of influenza virus vaccine | 42 | $1,113 | $27 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 11 | $195 | $18 |
2015: 15 services
| Professional service for preparation and provision of 1 or more antigens | 574 | $148,813 | $10 |
| Professional service for multiple injections of allergen | 684 | $80,736 | $8 |
| Short return visit (20+ min) | 633 | $53,437 | $54 |
| Test for allergy using allergenic extract | 126 | $38,928 | $5 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 397 | $33,061 | $49 |
| Test for allergy using allergenic extract injected into skin | 150 | $26,518 | $6 |
| New patient visit (45+ min) | 87 | $11,008 | $127 |
| Return visit (30+ min) | 69 | $6,960 | $85 |
| Professional service for preparation and provision of single-dose vial of allergen | 13 | $3,265 | $10 |
| New patient visit (60+ min) | 18 | $2,611 | $145 |
| Test to measure expiratory airflow and volume | 62 | $1,831 | $29 |
| Administration of influenza virus vaccine | 59 | $1,529 | $25 |
| Professional service for single injection of allergen | 19 | $1,394 | $7 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 59 | $708 | $12 |
| Test to measure the level of nitric oxide gas | 21 | $406 | $16 |
2014: 15 services
| Professional service for preparation and provision of 1 or more antigens | 556 | $144,419 | $10 |
| Professional service for multiple injections of allergen | 679 | $76,877 | $7 |
| Short return visit (20+ min) | 636 | $54,969 | $55 |
| Test for allergy using allergenic extract | 137 | $45,057 | $5 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 366 | $31,630 | $49 |
| Test for allergy using allergenic extract injected into skin | 152 | $26,753 | $6 |
| New patient visit (60+ min) | 59 | $9,342 | $158 |
| New patient visit (45+ min) | 35 | $4,475 | $128 |
| Return visit (30+ min) | 46 | $3,846 | $82 |
| Professional service for preparation and provision of single-dose vial of allergen | 12 | $3,054 | $10 |
| Test to measure expiratory airflow and volume | 65 | $1,857 | $29 |
| Administration of influenza virus vaccine | 61 | $1,554 | $25 |
| Test to measure the level of nitric oxide gas | 62 | $1,536 | $16 |
| Professional service for single injection of allergen | 23 | $1,526 | $6 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 60 | $708 | $12 |
2013: 15 services
| Professional service for preparation and provision of 1 or more antigens | 570 | $150,592 | $11 |
| Professional service for multiple injections of allergen | 687 | $86,707 | $8 |
| Short return visit (20+ min) | 664 | $59,175 | $54 |
| Test for allergy using allergenic extract | 156 | $54,540 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 420 | $39,410 | $52 |
| Test for allergy using allergenic extract injected into skin | 180 | $34,898 | $7 |
| New patient visit (60+ min) | 107 | $15,883 | $148 |
| Test to measure the level of nitric oxide gas | 159 | $4,481 | $18 |
| Return visit (30+ min) | 53 | $4,360 | $81 |
| Professional service for preparation and provision of single-dose vial of allergen | 13 | $3,557 | $10 |
| Administration of influenza virus vaccine | 78 | $1,987 | $25 |
| Test to measure expiratory airflow and volume | 64 | $1,938 | $28 |
| Professional service for single injection of allergen | 21 | $1,920 | $7 |
| New patient visit (45+ min) | 13 | $1,617 | $124 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 78 | $920 | $12 |
Medicaid work
$781,830 in 2024
Medicaid paid $781,830 for 19,378 billed services this clinician did in 2024, up to 843 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ANTIGEN THERAPY SERVICES | 690 | $224,624 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 14,139 | $163,804 |
| ANTIGEN THERAPY SERVICES | 176 | $124,984 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 622 | $84,544 |
| EVALUATION OF WHEEZING | 822 | $42,948 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 415 | $40,338 |
| Short return visit (20+ min) | 1,164 | $39,412 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 266 | $33,301 |
| Short return visit | 269 | $6,595 |
| Return visit (30+ min) | 108 | $6,002 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 44 | $4,678 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 123 | $4,199 |
| 2024 | 19,378 | 16 | 843 | $781,830 |
| 2023 | 23,774 | 17 | 769 | $860,252 |
| 2022 | 21,903 | 16 | 668 | $850,522 |
| 2021 | 21,398 | 12 | 668 | $776,947 |
| 2020 | 21,216 | 13 | 717 | $660,227 |
| 2019 | 17,897 | 11 | 546 | $675,290 |
| 2018 | 18,072 | 11 | 570 | $682,060 |
See the largest Medicaid services in earlier years
2023
| ANTIGEN THERAPY SERVICES | 1,007 | $329,660 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 17,663 | $203,485 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 793 | $106,465 |
| EVALUATION OF WHEEZING | 936 | $48,939 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 500 | $42,757 |
| Short return visit (20+ min) | 1,315 | $41,726 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 283 | $34,944 |
| ANTIGEN THERAPY SERVICES | 124 | $14,351 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 99 | $12,432 |
| Short return visit | 305 | $7,614 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 170 | $5,043 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 222 | $4,271 |
2022
| ANTIGEN THERAPY SERVICES | 974 | $332,931 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 16,134 | $193,100 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 774 | $103,118 |
| EVALUATION OF WHEEZING | 975 | $52,436 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 514 | $47,141 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 363 | $45,520 |
| Short return visit (20+ min) | 1,296 | $42,648 |
| ANTIGEN THERAPY SERVICES | 96 | $10,287 |
| Return visit (30+ min) | 140 | $8,095 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 196 | $6,072 |
| Short return visit | 162 | $3,744 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 153 | $3,451 |
2021
| ANTIGEN THERAPY SERVICES | 880 | $293,694 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 15,891 | $190,182 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 712 | $92,387 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 507 | $45,671 |
| Short return visit (20+ min) | 1,327 | $44,578 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 291 | $36,260 |
| EVALUATION OF WHEEZING | 437 | $22,858 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 753 | $22,407 |
| ANTIGEN THERAPY SERVICES | 240 | $20,930 |
| Return visit (30+ min) | 69 | $3,623 |
| IMMUNOTHERAPY ONE INJECTION | 276 | $2,926 |
| New patient visit (45+ min) | 15 | $1,432 |
2020
| ANTIGEN THERAPY SERVICES | 745 | $246,419 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 16,634 | $189,836 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 539 | $66,187 |
| EVALUATION OF WHEEZING | 738 | $40,142 |
| Short return visit (20+ min) | 1,106 | $38,181 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 375 | $32,246 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 171 | $21,247 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 253 | $7,685 |
| Return visit (30+ min) | 124 | $7,363 |
| ANTIGEN THERAPY SERVICES | 109 | $6,891 |
| IMMUNOTHERAPY ONE INJECTION | 391 | $3,614 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $264 |
2019
| ANTIGEN THERAPY SERVICES | 741 | $252,375 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 13,260 | $157,294 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 659 | $85,317 |
| EVALUATION OF WHEEZING | 1,023 | $55,336 |
| Short return visit (20+ min) | 1,134 | $38,527 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 448 | $38,497 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 231 | $28,617 |
| Return visit (30+ min) | 275 | $15,725 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 49 | $1,559 |
| ANTIGEN THERAPY SERVICES | 14 | $1,190 |
| IMMUNOTHERAPY ONE INJECTION | 63 | $853 |
2018
| ANTIGEN THERAPY SERVICES | 747 | $250,998 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 12,234 | $143,279 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 524 | $69,755 |
| EVALUATION OF WHEEZING | 1,042 | $60,270 |
| Short return visit (20+ min) | 1,147 | $48,072 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 387 | $34,622 |
| IMMUNOTHERAPY ONE INJECTION | 1,415 | $24,846 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 195 | $23,354 |
| Return visit (30+ min) | 278 | $19,735 |
| ANTIGEN THERAPY SERVICES | 91 | $6,727 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 12 | $403 |
Drugs they prescribed that Part D paid
$2,401,730
Pharmacies billed $2,401,730 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,156) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
3,967 generic and fewer than 11 brand-name prescriptions · $2,401,730 in drug cost · 104 antibiotic prescriptions to 78 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spiriva Respimat | 441 | $280,025 | $635 |
| Trelegy Ellipta | 347 | $262,290 | $756 |
| Dupixent | 49 | $183,178 | $3,738 |
| Breztri Aerosphere | 222 | $164,591 | $741 |
| Prolastin C | 11 | $141,920 | $12,902 |
See all 52 drugs
| Spiriva Respimat | 441 | $280,025 | $635 |
| Trelegy Ellipta | 347 | $262,290 | $756 |
| Dupixent | 49 | $183,178 | $3,738 |
| Breztri Aerosphere | 222 | $164,591 | $741 |
| Prolastin C | 11 | $141,920 | $12,902 |
| Symbicort | 514 | $141,834 | $276 |
| Dupixent | 39 | $138,620 | $3,554 |
| Xolair | 47 | $124,696 | $2,653 |
| Tezspire | 26 | $106,731 | $4,105 |
| Breyna | 342 | $67,845 | $198 |
| Breo Ellipta | 139 | $64,879 | $467 |
| Dulera | 165 | $59,656 | $362 |
| Nucala | 13 | $48,358 | $3,720 |
| Budesonide-Formoterol | 244 | $46,558 | $191 |
| Azelastine | 992 | $29,178 | $29 |
| Incruse Ellipta | 55 | $21,879 | $398 |
| Albuterol Sulfate Hfa | 563 | $21,773 | $39 |
| Combivent Respimat | 23 | $15,982 | $695 |
| Azelastine-Fluticasone | 140 | $14,606 | $104 |
| Xhance | 19 | $12,860 | $677 |
| Fluticasone Propionate | 826 | $11,040 | $13 |
| Airsupra | 18 | $10,758 | $598 |
| Anoro Ellipta | 15 | $10,288 | $686 |
| Wixela Inhub | 88 | $10,100 | $115 |
| Ipratropium | 344 | $9,741 | $28 |
| Pulmicort Flexhaler | 21 | $9,720 | $463 |
| Atrovent Hfa | 18 | $7,987 | $444 |
| Fluticasone-Salmeterol | 37 | $7,719 | $209 |
| Ventolin Hfa | 136 | $7,443 | $55 |
| Epinephrine | 32 | $6,887 | $215 |
| Qvar Redihaler | 18 | $6,657 | $370 |
| Arnuity Ellipta | 26 | $6,028 | $232 |
| Advair Hfa | 15 | $5,313 | $354 |
| Qnasl | 17 | $5,153 | $303 |
| Bevespi Aerosphere | 12 | $4,833 | $403 |
| Tacrolimus | 43 | $4,690 | $109 |
| Montelukast | 341 | $2,660 | $8 |
| Mometasone Furoate | 25 | $2,655 | $106 |
| Proair Respiclick | 11 | $1,597 | $145 |
| Theophylline Er | 33 | $1,194 | $36 |
| Clobetasol Propionate | 24 | $841 | $35 |
| Levalbuterol Tartrate Hfa | 14 | $609 | $43 |
| Triamcinolone Acetonide | 71 | $525 | $7 |
| Doxepin | 16 | $414 | $26 |
| Famotidine | 36 | $393 | $11 |
| Prednisone | 143 | $381 | $3 |
| Omeprazole | 65 | $360 | $6 |
| Azithromycin | 47 | $264 | $6 |
| Hydroxyzine | 31 | $206 | $7 |
| Levofloxacin | 37 | $154 | $4 |
| Levocetirizine Dihydrochloride | 14 | $95 | $7 |
| Fluconazole | 13 | $65 | $5 |
Year by year
| 2024 | 7,156 | 1,110 | 0% (0) | None | $2,401,730 |
| 2023 | 6,902 | 1,098 | 0% (0) | None | $2,644,548 |
| 2022 | 6,742 | 1,000 | 0% (0) | 51% | $2,279,238 |
| 2021 | 6,712 | 978 | 0% (0) | 50% | $2,154,462 |
| 2020 | 6,144 | 884 | 0% (0) | 51% | $1,818,150 |
| 2019 | 5,169 | 771 | 0% (0) | 50% | $1,675,965 |
| 2018 | 5,011 | 782 | 0% (0) | None | $1,437,338 |
| 2017 | 4,800 | 726 | 0% (0) | 50% | $1,330,078 |
| 2016 | 4,315 | 681 | 0% (0) | 54% | $1,282,454 |
| 2015 | 3,877 | 620 | 0% (0) | 58% | $1,338,196 |
| 2014 | 3,447 | 591 | None | 57% | $1,180,406 |
| 2013 | 3,512 | 598 | None | 60% | $519,257 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Symbicort | 1,182 | $581,250 | $492 |
| Takhzyro | 13 | $344,750 | $26,519 |
| Spiriva Respimat | 418 | $273,856 | $655 |
| Trelegy Ellipta | 265 | $217,521 | $821 |
| Breztri Aerosphere | 143 | $122,528 | $857 |
| Dupixent | 31 | $116,011 | $3,742 |
| Dupixent | 28 | $107,995 | $3,857 |
| Tezspire | 22 | $97,916 | $4,451 |
| Xolair | 30 | $87,017 | $2,901 |
| Budesonide-Formoterol | 192 | $55,251 | $288 |
| Breo Ellipta | 95 | $47,977 | $505 |
| Nucala | 13 | $46,950 | $3,612 |
| Azelastine | 912 | $38,113 | $42 |
| Incruse Ellipta | 70 | $32,281 | $461 |
| Dulera | 77 | $31,770 | $413 |
| Azelastine-Fluticasone | 105 | $18,353 | $175 |
| Albuterol Sulfate Hfa | 420 | $16,815 | $40 |
| Fluticasone Propionate | 768 | $16,747 | $22 |
| Combivent Respimat | 24 | $15,692 | $654 |
| Xhance | 23 | $14,374 | $625 |
| Ipratropium | 304 | $13,691 | $45 |
| Ventolin Hfa | 181 | $11,273 | $62 |
| Pulmicort Flexhaler | 17 | $10,430 | $614 |
| Atrovent Hfa | 21 | $10,385 | $495 |
| Epinephrine | 28 | $9,262 | $331 |
| Qvar Redihaler | 22 | $7,935 | $361 |
| Fluticasone-Salmeterol | 23 | $7,338 | $319 |
| Advair Diskus | 12 | $7,018 | $585 |
| Bevespi Aerosphere | 13 | $5,835 | $449 |
| Montelukast | 422 | $5,547 | $13 |
| Breyna | 19 | $4,991 | $263 |
| Clobetasol Propionate | 22 | $4,820 | $219 |
| Wixela Inhub | 19 | $4,613 | $243 |
| Tacrolimus | 27 | $4,462 | $165 |
| Mometasone Furoate | 27 | $3,174 | $118 |
| Hydroxyzine | 61 | $1,582 | $26 |
| Levalbuterol Tartrate Hfa | 27 | $1,496 | $55 |
| Theophylline Er | 31 | $1,461 | $47 |
| Olopatadine | 67 | $1,264 | $19 |
| Doxepin | 24 | $1,232 | $51 |
| Famotidine | 42 | $1,007 | $24 |
| Triamcinolone Acetonide | 97 | $881 | $9 |
| Levocetirizine Dihydrochloride | 28 | $584 | $21 |
| Omeprazole | 63 | $548 | $9 |
| Prednisone | 156 | $491 | $3 |
| Levofloxacin | 44 | $412 | $9 |
| Azithromycin | 38 | $246 | $6 |
| Fluconazole | 15 | $168 | $11 |
| Cyproheptadine | 11 | $107 | $10 |
2022: 52 drugs
| Symbicort | 1,255 | $603,673 | $481 |
| Spiriva Respimat | 445 | $284,920 | $640 |
| Takhzyro | 11 | $283,851 | $25,805 |
| Trelegy Ellipta | 183 | $145,397 | $795 |
| Dupixent | 37 | $133,038 | $3,596 |
| Budesonide-Formoterol | 172 | $56,300 | $327 |
| Azelastine | 922 | $44,634 | $48 |
| Dupixent | 12 | $43,290 | $3,608 |
| Dulera | 94 | $41,067 | $437 |
| Breo Ellipta | 77 | $37,194 | $483 |
| Incruse Ellipta | 76 | $34,236 | $450 |
| Breztri Aerosphere | 38 | $33,926 | $893 |
| Combivent Respimat | 35 | $26,259 | $750 |
| Advair Diskus | 58 | $25,103 | $433 |
| Albuterol Sulfate Hfa | 470 | $21,959 | $47 |
| Azelastine-Fluticasone | 108 | $20,910 | $194 |
| Spiriva Handihaler | 15 | $18,094 | $1,206 |
| Ipratropium | 293 | $15,783 | $54 |
| Xhance | 22 | $14,340 | $652 |
| Serevent Diskus | 17 | $14,207 | $836 |
| Stiolto Respimat | 28 | $13,403 | $479 |
| Pulmicort Flexhaler | 24 | $12,222 | $509 |
| Fluticasone Propionate | 786 | $11,815 | $15 |
| Qvar Redihaler | 24 | $9,255 | $386 |
| Ventolin Hfa | 128 | $8,472 | $66 |
| Bevespi Aerosphere | 19 | $8,293 | $436 |
| Wixela Inhub | 35 | $8,049 | $230 |
| Epinephrine | 23 | $7,279 | $316 |
| Fluticasone-Salmeterol | 37 | $6,998 | $189 |
| Flovent Hfa | 16 | $5,909 | $369 |
| Tacrolimus | 20 | $5,577 | $279 |
| Mometasone Furoate | 28 | $5,504 | $197 |
| Asmanex | 14 | $4,862 | $347 |
| Montelukast | 311 | $4,850 | $16 |
| Armonair Digihaler | 17 | $4,368 | $257 |
| Clobetasol Propionate | 28 | $3,965 | $142 |
| Arnuity Ellipta | 11 | $3,084 | $280 |
| Olopatadine | 57 | $1,611 | $28 |
| Proair Hfa | 14 | $1,511 | $108 |
| Levalbuterol Tartrate Hfa | 26 | $1,507 | $58 |
| Theophylline | 27 | $1,405 | $52 |
| Doxepin | 20 | $627 | $31 |
| Prednisone | 208 | $608 | $3 |
| Omeprazole | 46 | $584 | $13 |
| Triamcinolone Acetonide | 88 | $554 | $6 |
| Clarithromycin | 14 | $473 | $34 |
| Azithromycin | 46 | $346 | $8 |
| Hydroxyzine | 43 | $344 | $8 |
| Famotidine | 16 | $344 | $21 |
| Levocetirizine Dihydrochloride | 22 | $300 | $14 |
| Cyproheptadine | 12 | $264 | $22 |
| Levofloxacin | 29 | $178 | $6 |
2021: 55 drugs
| Symbicort | 1,197 | $580,558 | $485 |
| Takhzyro | 13 | $325,690 | $25,053 |
| Spiriva Respimat | 528 | $302,628 | $573 |
| Prolastin C | 12 | $140,107 | $11,676 |
| Dupixent | 30 | $102,368 | $3,412 |
| Budesonide-Formoterol | 206 | $67,058 | $326 |
| Dulera | 126 | $50,631 | $402 |
| Dupixent | 12 | $41,132 | $3,428 |
| Trelegy Ellipta | 61 | $41,053 | $673 |
| Azelastine | 859 | $38,591 | $45 |
| Nucala | 11 | $33,597 | $3,054 |
| Breo Ellipta | 66 | $31,900 | $483 |
| Stiolto Respimat | 53 | $30,679 | $579 |
| Spiriva | 20 | $22,746 | $1,137 |
| Incruse Ellipta | 56 | $21,776 | $389 |
| Advair Diskus | 41 | $21,702 | $529 |
| Albuterol Sulfate Hfa | 411 | $21,199 | $52 |
| Combivent Respimat | 37 | $20,052 | $542 |
| Xhance | 25 | $17,480 | $699 |
| Ipratropium | 312 | $17,081 | $55 |
| Azelastine-Fluticasone | 82 | $14,568 | $178 |
| Flovent Hfa | 38 | $14,413 | $379 |
| Pulmicort Flexhaler | 40 | $14,183 | $355 |
| Serevent Diskus | 21 | $14,167 | $675 |
| Fluticasone Propionate | 786 | $11,505 | $15 |
| Wixela Inhub | 45 | $9,533 | $212 |
| Atrovent Hfa | 20 | $8,926 | $446 |
| Ventolin Hfa | 138 | $8,892 | $64 |
| Mometasone Furoate | 50 | $7,740 | $155 |
| Bevespi Aerosphere | 16 | $6,656 | $416 |
| Epinephrine | 23 | $6,592 | $287 |
| Asmanex | 19 | $6,371 | $335 |
| Olopatadine | 119 | $6,059 | $51 |
| Fluticasone-Salmeterol | 27 | $5,798 | $215 |
| Theo-24 | 21 | $5,556 | $265 |
| Armonair Digihaler | 19 | $4,660 | $245 |
| Montelukast | 301 | $3,433 | $11 |
| Tacrolimus | 15 | $3,357 | $224 |
| Qvar Redihaler | 12 | $3,108 | $259 |
| Proair Hfa | 21 | $2,548 | $121 |
| Levalbuterol Tartrate Hfa | 25 | $1,884 | $75 |
| Theophylline | 39 | $1,698 | $44 |
| Clobetasol Propionate | 26 | $1,612 | $62 |
| Prednisone | 237 | $781 | $3 |
| Triamcinolone Acetonide | 108 | $697 | $6 |
| Levofloxacin | 47 | $580 | $12 |
| Esomeprazole Magnesium | 11 | $577 | $52 |
| Clarithromycin | 13 | $475 | $37 |
| Doxepin | 14 | $453 | $32 |
| Cyproheptadine | 19 | $435 | $23 |
| Hydroxyzine | 20 | $384 | $19 |
| Omeprazole | 44 | $356 | $8 |
| Sodium Chloride | 17 | $293 | $17 |
| Levocetirizine Dihydrochloride | 17 | $227 | $13 |
| Azithromycin | 18 | $187 | $10 |
2020: 52 drugs
| Symbicort | 1,115 | $532,537 | $478 |
| Takhzyro | 11 | $316,204 | $28,746 |
| Spiriva Respimat | 433 | $234,290 | $541 |
| Prolastin C | 13 | $150,056 | $11,543 |
| Dulera | 155 | $58,808 | $379 |
| Budesonide-Formoterol | 159 | $51,340 | $323 |
| Nucala | 12 | $35,557 | $2,963 |
| Azelastine | 738 | $32,773 | $44 |
| Breo Ellipta | 55 | $22,984 | $418 |
| Incruse Ellipta | 58 | $21,951 | $378 |
| Advair Diskus | 39 | $21,646 | $555 |
| Combivent Respimat | 43 | $20,644 | $480 |
| Serevent Diskus | 27 | $18,917 | $701 |
| Albuterol Sulfate Hfa | 304 | $17,709 | $58 |
| Spiriva | 24 | $16,991 | $708 |
| Ipratropium | 284 | $15,863 | $56 |
| Azelastine-Fluticasone | 73 | $14,799 | $203 |
| Flovent Hfa | 40 | $14,721 | $368 |
| Asmanex | 31 | $14,031 | $453 |
| Pulmicort Flexhaler | 46 | $13,554 | $295 |
| Fluticasone Propionate | 712 | $13,263 | $19 |
| Stiolto Respimat | 27 | $13,177 | $488 |
| Ventolin Hfa | 181 | $11,520 | $64 |
| Olopatadine | 161 | $9,212 | $57 |
| Anoro Ellipta | 14 | $7,554 | $540 |
| Qvar Redihaler | 31 | $7,534 | $243 |
| Epinephrine | 23 | $7,409 | $322 |
| Wixela Inhub | 21 | $6,816 | $325 |
| Mometasone Furoate | 33 | $6,415 | $194 |
| Dymista | 21 | $5,196 | $247 |
| Atrovent Hfa | 12 | $5,173 | $431 |
| Fluticasone-Salmeterol | 28 | $5,107 | $182 |
| Theo-24 | 16 | $4,266 | $267 |
| Montelukast | 298 | $3,747 | $13 |
| Pazeo | 13 | $3,132 | $241 |
| Proair Hfa | 45 | $2,925 | $65 |
| Esomeprazole Magnesium | 24 | $2,095 | $87 |
| Proair Respiclick | 20 | $2,064 | $103 |
| Clobetasol Propionate | 20 | $1,794 | $90 |
| Theophylline | 41 | $1,779 | $43 |
| Xopenex Hfa | 13 | $923 | $71 |
| Doxepin | 18 | $804 | $45 |
| Prednisone | 244 | $759 | $3 |
| Triamcinolone Acetonide | 98 | $717 | $7 |
| Levofloxacin | 54 | $572 | $11 |
| Clarithromycin | 15 | $473 | $32 |
| Doxycycline Hyclate | 19 | $377 | $20 |
| Sodium Chloride | 16 | $270 | $17 |
| Omeprazole | 36 | $267 | $7 |
| Hydroxyzine | 23 | $217 | $9 |
| Levocetirizine Dihydrochloride | 21 | $207 | $10 |
| Azithromycin | 20 | $115 | $6 |
2019: 43 drugs
| Symbicort | 1,062 | $468,389 | $441 |
| Spiriva Respimat | 383 | $199,619 | $521 |
| Prolastin C | 12 | $156,666 | $13,055 |
| Dulera | 150 | $54,978 | $367 |
| Azelastine | 644 | $28,820 | $45 |
| Advair Diskus | 45 | $27,509 | $611 |
| Serevent Diskus | 51 | $25,513 | $500 |
| Dymista | 65 | $14,020 | $216 |
| Ventolin Hfa | 193 | $12,830 | $66 |
| Pulmicort Flexhaler | 47 | $12,752 | $271 |
| Asmanex | 26 | $11,364 | $437 |
| Olopatadine | 136 | $10,772 | $79 |
| Stiolto Respimat | 27 | $10,731 | $397 |
| Fluticasone Propionate | 660 | $10,121 | $15 |
| Spiriva | 12 | $10,083 | $840 |
| Combivent Respimat | 24 | $9,884 | $412 |
| Qvar Redihaler | 41 | $9,209 | $225 |
| Ipratropium | 205 | $8,476 | $41 |
| Breo Ellipta | 23 | $7,982 | $347 |
| Albuterol Sulfate Hfa | 130 | $7,362 | $57 |
| Incruse Ellipta | 20 | $6,756 | $338 |
| Flovent Hfa | 20 | $6,617 | $331 |
| Proair Hfa | 68 | $4,877 | $72 |
| Mometasone Furoate | 32 | $4,138 | $129 |
| Epinephrine | 17 | $4,121 | $242 |
| Fluticasone-Salmeterol | 19 | $3,645 | $192 |
| Montelukast | 281 | $3,618 | $13 |
| Pazeo | 12 | $2,722 | $227 |
| Esomeprazole Magnesium | 14 | $2,306 | $165 |
| Clobetasol Propionate | 18 | $2,154 | $120 |
| Proair Respiclick | 24 | $1,920 | $80 |
| Doxepin | 16 | $1,034 | $65 |
| Flunisolide | 12 | $849 | $71 |
| Xopenex Hfa | 12 | $840 | $70 |
| Clarithromycin | 19 | $787 | $41 |
| Prednisone | 285 | $773 | $3 |
| Levofloxacin | 70 | $612 | $9 |
| Triamcinolone Acetonide | 46 | $399 | $9 |
| Fluconazole | 16 | $354 | $22 |
| Omeprazole | 32 | $250 | $8 |
| Hydroxyzine | 23 | $202 | $9 |
| Sodium Chloride | 11 | $186 | $17 |
| Azithromycin | 18 | $120 | $7 |
2018: 43 drugs
| Symbicort | None | 930 | $354,549 | $381 |
| Haegarda | None | 18 | $342,705 | $19,039 |
| Spiriva Respimat | None | 269 | $128,445 | $477 |
| Gammagard Liquid | Immune globulin | 42 | $58,408 | $1,391 |
| Dulera | None | 153 | $57,144 | $373 |
| Advair Diskus | None | 81 | $46,786 | $578 |
| Nucala | None | 11 | $32,186 | $2,926 |
| Azelastine | None | 571 | $26,179 | $46 |
| Xolair | None | 12 | $25,365 | $2,114 |
| Serevent Diskus | None | 38 | $19,397 | $510 |
| Dymista | None | 80 | $17,099 | $214 |
| Spiriva | None | 24 | $15,428 | $643 |
| Ventolin Hfa | None | 229 | $14,497 | $63 |
| Asmanex | None | 36 | $12,725 | $353 |
| Fluticasone Propionate | None | 688 | $9,677 | $14 |
| Stiolto Respimat | None | 23 | $8,539 | $371 |
| Ipratropium | None | 235 | $7,943 | $34 |
| Proair Hfa | None | 111 | $7,936 | $71 |
| Bevespi Aerosphere | None | 19 | $6,779 | $357 |
| Pulmicort Flexhaler | None | 24 | $6,710 | $280 |
| Flovent Hfa | None | 21 | $6,613 | $315 |
| Olopatadine | None | 112 | $5,788 | $52 |
| Qvar Redihaler | None | 24 | $5,497 | $229 |
| Qvar | None | 21 | $5,364 | $255 |
| Breo Ellipta | None | 13 | $5,148 | $396 |
| Alvesco | None | 13 | $4,637 | $357 |
| Incruse Ellipta | None | 14 | $4,595 | $328 |
| Mometasone Furoate | None | 32 | $4,103 | $128 |
| Pazeo | None | 20 | $4,005 | $200 |
| Montelukast | None | 320 | $3,723 | $12 |
| Fluticasone-Salmeterol | None | 20 | $2,367 | $118 |
| Proair Respiclick | None | 30 | $1,741 | $58 |
| Xopenex Hfa | None | 21 | $1,467 | $70 |
| Levofloxacin | None | 64 | $869 | $14 |
| Prednisone | None | 246 | $856 | $3 |
| Clarithromycin | None | 11 | $620 | $56 |
| Triamcinolone Acetonide | None | 55 | $578 | $11 |
| Doxepin | None | 13 | $577 | $44 |
| Fluconazole | None | 20 | $506 | $25 |
| Omeprazole | None | 54 | $329 | $6 |
| Hydroxyzine | None | 25 | $290 | $12 |
| Azithromycin | None | 36 | $284 | $8 |
| Dextrose in Water | None | 11 | $43 | $4 |
2017: 46 drugs
| Cinryze | None | 14 | $507,458 | $36,247 |
| Symbicort | None | 890 | $301,788 | $339 |
| Spiriva Respimat | None | 198 | $79,992 | $404 |
| Dulera | None | 151 | $51,783 | $343 |
| Gammagard Liquid | Immune globulin | 30 | $38,178 | $1,273 |
| Nucala | None | 13 | $36,275 | $2,790 |
| Advair Diskus | None | 66 | $35,484 | $538 |
| Spiriva | None | 54 | $26,541 | $491 |
| Azelastine | None | 547 | $24,360 | $45 |
| Serevent Diskus | None | 50 | $21,592 | $432 |
| Qvar | None | 77 | $19,009 | $247 |
| Dymista | None | 71 | $14,893 | $210 |
| Flovent Hfa | None | 42 | $14,584 | $347 |
| Proair Hfa | None | 170 | $11,935 | $70 |
| Mometasone Furoate | None | 53 | $10,503 | $198 |
| Epipen 2-Pak | None | 16 | $9,780 | $611 |
| Ventolin Hfa | None | 160 | $8,999 | $56 |
| Asmanex | None | 30 | $8,709 | $290 |
| Fluticasone Propionate | None | 631 | $8,273 | $13 |
| Combivent Respimat | None | 13 | $6,587 | $507 |
| Nasonex | None | 25 | $6,185 | $247 |
| Ipratropium | None | 170 | $5,614 | $33 |
| Olopatadine | None | 61 | $5,133 | $84 |
| Stiolto Respimat | None | 11 | $4,870 | $443 |
| Atrovent Hfa | None | 11 | $3,732 | $339 |
| Alvesco | None | 11 | $3,678 | $334 |
| Montelukast | None | 324 | $3,317 | $10 |
| Pazeo | None | 16 | $3,244 | $203 |
| Pataday | None | 16 | $2,946 | $184 |
| Pulmicort Flexhaler | None | 13 | $2,558 | $197 |
| Clobetasol Propionate | None | 12 | $2,380 | $198 |
| Proair Respiclick | None | 40 | $2,285 | $57 |
| Qnasl | None | 11 | $2,264 | $206 |
| Xopenex Hfa | None | 27 | $1,890 | $70 |
| Esomeprazole Magnesium | None | 17 | $1,345 | $79 |
| Prednisone | None | 270 | $877 | $3 |
| Doxepin | None | 20 | $719 | $36 |
| Fluconazole | None | 21 | $670 | $32 |
| Clarithromycin | None | 15 | $640 | $43 |
| Levofloxacin | None | 78 | $589 | $8 |
| Epinastine | None | 11 | $509 | $46 |
| Hydroxyzine | None | 37 | $504 | $14 |
| Azithromycin | None | 45 | $315 | $7 |
| Triamcinolone Acetonide | None | 32 | $296 | $9 |
| Levocetirizine Dihydrochloride | None | 17 | $185 | $11 |
| Omeprazole | None | 34 | $173 | $5 |
2016: 45 drugs
| Cinryze | 18 | $554,405 | $30,800 |
| Symbicort | 800 | $254,876 | $319 |
| Spiriva | 125 | $50,629 | $405 |
| Dulera | 136 | $43,971 | $323 |
| Spiriva Respimat | 116 | $40,515 | $349 |
| Advair Diskus | 66 | $26,897 | $408 |
| Qvar | 110 | $25,802 | $235 |
| Azelastine | 544 | $23,786 | $44 |
| Nasonex | 71 | $17,993 | $253 |
| Serevent Diskus | 37 | $13,753 | $372 |
| Flovent Hfa | 36 | $12,358 | $343 |
| Epipen 2-Pak | 18 | $10,541 | $586 |
| Dymista | 48 | $10,335 | $215 |
| Mometasone Furoate | 54 | $10,289 | $191 |
| Asmanex | 36 | $9,370 | $260 |
| Proair Hfa | 157 | $9,284 | $59 |
| Fluticasone Propionate | 597 | $7,016 | $12 |
| Pataday | 31 | $6,777 | $219 |
| Foradil | 16 | $6,093 | $381 |
| Restasis | 13 | $5,636 | $434 |
| Alvesco | 18 | $5,478 | $304 |
| Nexium | 12 | $4,837 | $403 |
| Atrovent Hfa | 15 | $4,575 | $305 |
| Ipratropium | 157 | $4,454 | $28 |
| Qnasl | 18 | $4,285 | $238 |
| Ventolin Hfa | 74 | $3,941 | $53 |
| Pazeo | 20 | $3,360 | $168 |
| Olopatadine | 26 | $3,080 | $118 |
| Pulmicort Flexhaler | 14 | $2,785 | $199 |
| Esomeprazole Magnesium | 15 | $2,711 | $181 |
| Clobetasol Propionate | 19 | $2,588 | $136 |
| Montelukast | 218 | $2,274 | $10 |
| Xopenex Hfa | 20 | $1,397 | $70 |
| Proair Respiclick | 22 | $1,343 | $61 |
| Clarithromycin | 20 | $1,029 | $51 |
| Doxepin | 19 | $946 | $50 |
| Epinastine | 12 | $901 | $75 |
| Fluconazole | 18 | $812 | $45 |
| Triamcinolone Acetonide | 50 | $733 | $15 |
| Prednisone | 208 | $727 | $3 |
| Levothyroxine | 18 | $521 | $29 |
| Levofloxacin | 42 | $498 | $12 |
| Omeprazole | 51 | $311 | $6 |
| Valsartan | 11 | $117 | $11 |
| Hydroxyzine | 15 | $97 | $6 |
2015: 40 drugs
| Cinryze | None | 12 | $646,502 | $53,875 |
| Symbicort | None | 601 | $189,327 | $315 |
| Spiriva | None | 164 | $63,434 | $387 |
| Gammagard Liquid | Immune globulin | 12 | $41,079 | $3,423 |
| Advair Diskus | None | 115 | $39,808 | $346 |
| Xolair | None | 11 | $38,671 | $3,516 |
| Dulera | None | 102 | $36,589 | $359 |
| Qvar | None | 164 | $35,437 | $216 |
| Azelastine | None | 464 | $27,349 | $59 |
| Nasonex | None | 127 | $26,743 | $211 |
| Foradil | None | 61 | $19,008 | $312 |
| Proair Hfa | None | 267 | $15,175 | $57 |
| Patanol | None | 52 | $14,692 | $283 |
| Dymista | None | 55 | $9,697 | $176 |
| Nexium | None | 24 | $8,872 | $370 |
| Asmanex | None | 28 | $7,903 | $282 |
| Epipen 2-Pak | None | 17 | $7,487 | $440 |
| Fluticasone Propionate | None | 546 | $7,200 | $13 |
| Alvesco | None | 18 | $6,375 | $354 |
| Flovent Hfa | None | 14 | $6,068 | $433 |
| Ipratropium | None | 150 | $4,732 | $32 |
| Pataday | None | 20 | $4,667 | $233 |
| Combivent Respimat | None | 14 | $4,592 | $328 |
| Pulmicort Flexhaler | None | 15 | $3,145 | $210 |
| Breo Ellipta | None | 11 | $2,942 | $267 |
| Montelukast | None | 183 | $2,818 | $15 |
| Ventolin Hfa | None | 37 | $1,834 | $50 |
| Clarithromycin | None | 19 | $1,237 | $65 |
| Cyproheptadine | None | 23 | $826 | $36 |
| Ethambutol | None | 11 | $625 | $57 |
| Triamcinolone Acetonide | None | 36 | $623 | $17 |
| Epinastine | None | 12 | $610 | $51 |
| Doxepin | None | 26 | $602 | $23 |
| Theophylline Anhydrous | None | 24 | $576 | $24 |
| Hydroxyzine | None | 22 | $495 | $22 |
| Levofloxacin | None | 41 | $410 | $10 |
| Levothyroxine | None | 28 | $406 | $14 |
| Prednisone | None | 112 | $396 | $4 |
| Omeprazole | None | 29 | $187 | $6 |
| Ranitidine | None | 13 | $89 | $7 |
2014: 37 drugs
| Cinryze | 12 | $648,123 | $54,010 |
| Symbicort | 490 | $139,596 | $285 |
| Advair Diskus | 156 | $52,028 | $334 |
| Spiriva | 138 | $49,739 | $360 |
| Dulera | 90 | $26,527 | $295 |
| Qvar | 134 | $25,490 | $190 |
| Azelastine | 334 | $24,776 | $74 |
| Nasonex | 140 | $24,507 | $175 |
| Foradil | 52 | $15,770 | $303 |
| Proair Hfa | 236 | $12,869 | $55 |
| Fluticasone Propionate | 538 | $9,667 | $18 |
| Asmanex | 36 | $8,928 | $248 |
| Alvesco | 24 | $8,317 | $347 |
| Pataday | 49 | $8,172 | $167 |
| Flovent Hfa | 16 | $5,534 | $346 |
| Patanase | 22 | $5,282 | $240 |
| Astepro | 29 | $4,783 | $165 |
| Epipen 2-Pak | 12 | $4,114 | $343 |
| Dymista | 26 | $4,023 | $155 |
| Ipratropium | 116 | $3,858 | $33 |
| Patanol | 23 | $3,810 | $166 |
| Montelukast | 146 | $3,787 | $26 |
| Nexium | 12 | $2,855 | $238 |
| Clarithromycin | 36 | $2,751 | $76 |
| Ventolin Hfa | 26 | $1,241 | $48 |
| Hydroxyzine | 33 | $845 | $26 |
| Triamcinolone Acetonide | 33 | $741 | $22 |
| Epinastine | 11 | $623 | $57 |
| Levofloxacin | 41 | $617 | $15 |
| Prednisone | 118 | $447 | $4 |
| Levothyroxine | 36 | $444 | $12 |
| Levocetirizine Dihydrochloride | 12 | $328 | $27 |
| Doxepin | 20 | $286 | $14 |
| Theophylline Anhydrous | 11 | $266 | $24 |
| Omeprazole | 34 | $255 | $8 |
| Cyproheptadine | 12 | $220 | $18 |
| Ranitidine | 12 | $73 | $6 |
2013: 40 drugs
| Symbicort | 482 | $123,706 | $257 |
| Spiriva | 179 | $55,723 | $311 |
| Advair Diskus | 165 | $50,944 | $309 |
| Xolair | 11 | $33,681 | $3,062 |
| Nasonex | 139 | $22,591 | $163 |
| Qvar | 130 | $22,340 | $172 |
| Dulera | 79 | $21,255 | $269 |
| Azelastine | 272 | $21,079 | $77 |
| Foradil | 73 | $18,159 | $249 |
| Fluticasone Propionate | 446 | $12,304 | $28 |
| Astepro | 73 | $12,010 | $165 |
| Asmanex | 51 | $11,519 | $226 |
| Pataday | 68 | $9,624 | $142 |
| Proair Hfa | 187 | $9,268 | $50 |
| Patanase | 39 | $6,754 | $173 |
| Flovent Hfa | 19 | $6,035 | $318 |
| Nexium | 20 | $4,538 | $227 |
| Patanol | 32 | $4,417 | $138 |
| Epipen 2-Pak | 17 | $4,399 | $259 |
| Clarithromycin | 38 | $4,144 | $109 |
| Alvesco | 20 | $4,079 | $204 |
| Montelukast | 127 | $3,638 | $29 |
| Ventolin Hfa | 80 | $3,491 | $44 |
| Aciphex | 11 | $3,475 | $316 |
| Ipratropium | 105 | $3,199 | $30 |
| Veramyst | 16 | $1,855 | $116 |
| Triamcinolone Acetonide | 59 | $1,527 | $26 |
| Epinastine | 13 | $1,063 | $82 |
| Hydroxyzine | 32 | $1,015 | $32 |
| Levofloxacin | 61 | $873 | $14 |
| Proventil Hfa | 12 | $741 | $62 |
| Xopenex Hfa | 12 | $607 | $51 |
| Clobetasol Propionate | 15 | $602 | $40 |
| Omeprazole | 30 | $432 | $14 |
| Prednisone | 134 | $415 | $3 |
| Doxepin | 27 | $263 | $10 |
| Theophylline Anhydrous | 14 | $233 | $17 |
| Levothyroxine | 14 | $144 | $10 |
| Ranitidine | 11 | $78 | $7 |
| Fluconazole | 11 | $66 | $6 |
Money from drug and device companies
$5,873 in 2025
| 2025 | 19 | 110 | $3,775 | $5,873 |
| 2024 | 13 | 97 | $11,550 | $14,169 |
| 2023 | 15 | 73 | $5,700 | $6,911 |
| 2022 | 16 | 53 | $3,825 | $4,627 |
| 2021 | 13 | 53 | $3,450 | $4,252 |
| 2020 | 13 | 46 | $8,290 | $8,971 |
| 2019 | 13 | 95 | $28,105 | $33,029 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $4,446 | 24 payments
|
| Genzyme | Dupixent | $240 | 14 payments
|
| Novartis Pharmaceuticals | Xolair | $187 | 10 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $177 | 7 payments
|
| Sanofi-Aventis U.S. | Dupixent | $155 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $144 | 3 payments
|
See all 86 published payments
| Genzyme | Meals · 2025-12-19 | Dupixent | $7 |
| Genzyme | Meals · 2025-12-19 | Dupixent | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-16 | Fasenra | $16 |
| Incyte | Meals · 2025-12-11 | Opzelura | $17 |
| Regeneron Healthcare Solutions | Meals · 2025-12-09 | Dupixent | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-05 | Hyqvia | $23 |
| GlaxoSmithKline | Meals · 2025-12-04 | Nucala | $16 |
| BioCryst US Sales Co. | Meals · 2025-12-04 | Orladeyo | $29 |
| Amgen | Meals · 2025-12-01 | Tezspire | $15 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-11-24 | Tezspire | $450 |
| Galderma Laboratories L.P. | Meals · 2025-11-06 | Nemluvio | $14 |
| Grifols USA | Meals · 2025-11-06 | Prolastin-C Liquid | $22 |
| ARS Pharmaceuticals Operations | Meals · 2025-10-29 | Neffy | $28 |
| Novartis Pharmaceuticals | Meals · 2025-10-27 | Rhapsido | $8 |
| Genzyme | Meals · 2025-10-27 | Dupixent | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-25 | Fasenra | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-23 | Airsupra | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-22 | Cuvitru | $17 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-10-07 | Airsupra | $525 |
| Genzyme | Meals · 2025-10-02 | Dupixent | $13 |
| Baxter Healthcare | Meals · 2025-09-29 | Hillrom - Monarch Airway Clearance System | $18 |
| Grifols USA | Meals · 2025-09-25 | Prolastin-C Liquid | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-23 | Fasenra | $32 |
| BioCryst US Sales Co. | Meals · 2025-09-19 | Orladeyo | $31 |
| Grifols USA | Meals · 2025-09-11 | Prolastin-C Liquid | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-10 | Fasenra | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-02 | Tezspire | $24 |
| Novartis Pharmaceuticals | Meals · 2025-08-29 | None | $5 |
| Genzyme | Meals · 2025-08-29 | Dupixent | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-27 | Tezspire | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-26 | Fasenra | $29 |
| Abbvie | Meals · 2025-08-23 | Rinvoq | $23 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-15 | Hyqvia | $18 |
| Novartis Pharmaceuticals | Meals · 2025-08-12 | None | $18 |
| Genzyme | Meals · 2025-08-04 | Dupixent | $22 |
| Amgen | Meals · 2025-07-30 | None | $18 |
| CSL Behring | Meals · 2025-07-15 | Andembry | $19 |
| BioCryst US Sales Co. | Meals · 2025-07-10 | Orladeyo | $23 |
| Novartis Pharmaceuticals | Meals · 2025-07-09 | None | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-08 | Fasenra | $30 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-07-03 | Tezspire | $250 |
| Baxter Healthcare | Meals · 2025-06-30 | Hillrom - Monarch Airway Clearance System | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-24 | Fasenra | $14 |
| Pharming Healthcare | Meals · 2025-06-18 | Ruconest | $16 |
| Abbvie | Meals · 2025-06-09 | Rinvoq | $15 |
| Genzyme | Meals · 2025-06-05 | Dupixent | $16 |
| Grifols USA | Meals · 2025-05-29 | Prolastin-C Liquid | $20 |
| Novartis Pharmaceuticals | Meals · 2025-05-28 | Xolair | $8 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-05-26 | Airsupra | $450 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-05-23 | Tezspire | $1,050 |
| ARS Pharmaceuticals Operations | Meals · 2025-05-19 | Neffy | $30 |
| Genzyme | Education · 2025-05-12 | Dupixent | $8 |
| Genzyme | Meals · 2025-05-12 | Dupixent | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-10 | Fasenra | $28 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Xolair | $11 |
| Genzyme | Meals · 2025-05-07 | Dupixent | $8 |
| Novartis Pharmaceuticals | Meals · 2025-05-06 | None | $30 |
| Genzyme | Meals · 2025-04-24 | Dupixent | $18 |
| Amgen | Meals · 2025-04-23 | Tezspire | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-22 | Fasenra | $18 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-22 | Neffy | $28 |
| Sanofi-Aventis U.S. | Education · 2025-04-21 | Dupixent | $55 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-10 | Hyqvia | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-04-05 | Dupixent | $37 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-03 | Fasenra | $29 |
| Amgen | Meals · 2025-04-01 | Tezspire | $16 |
| Sanofi-Aventis U.S. | Education · 2025-03-31 | Dupixent | $100 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-04 | Tezspire | $20 |
| Optinose US | Meals · 2025-02-26 | Xhance | $17 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-02-25 | Airsupra | $250 |
| Genzyme | Meals · 2025-02-24 | Dupixent | $16 |
| Genzyme | Meals · 2025-02-21 | Dupixent | $7 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-02-20 | Airsupra | $800 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-12 | None | $121 |
| Novartis Pharmaceuticals | Meals · 2025-02-11 | None | $60 |
| Novartis Pharmaceuticals | Meals · 2025-02-10 | None | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-02-10 | Dupixent | $78 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-10 | Cuvitru | $75 |
| Pfizer | Education · 2025-02-05 | Cibinqo | $15 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-31 | Hyqvia | $16 |
| Novartis Pharmaceuticals | Meals · 2025-01-29 | Xolair | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-28 | Fasenra | $29 |
| CSL Behring | Meals · 2025-01-23 | Hizentra | $15 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-10 | Hyqvia | $12 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-02 | Airsupra | $182 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $14,169
| AstraZeneca Pharmaceuticals LP | Airsupra | $13,467 | 28 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $139 | 20 payments
|
| Genzyme | Dupixent | $136 | 9 payments
|
| Novartis Pharmaceuticals | Xolair | $100 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Hyqvia | $76 | 3 payments
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $54 | 3 payments
|
| Optinose US | Xhance | $49 | 2 payments
|
| Pfizer | Octagam Immune Globulin (Human) | $37 | 2 payments
|
| Amgen | Tezspire | $32 | 2 payments
|
| Abbvie | Rinvoq | $27 | 1 payment
|
| Hikma Pharmaceuticals USA | Ryaltris | $25 | 1 payment
|
| Incyte | Opzelura | $15 | 1 payment
|
| Galderma Laboratories L.P. | None | $13 | 1 payment
|
2023: $6,911
| AstraZeneca Pharmaceuticals LP | Tezspire | $3,870 | 11 payments
|
| Amgen | Tezspire | $2,271 | 7 payments
|
| Pfizer | Octagam Immune Globulin (Human) | $129 | 7 payments
|
| Regeneron Healthcare Solutions | Dupixent | $129 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $104 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $75 | 1 payment
|
| kaleo | Auvi-Q | $54 | 2 payments
|
| Grifols USA | Xembify | $53 | 2 payments
|
| Pharming Healthcare | Ruconest | $53 | 3 payments
|
| Octapharma USA | Cutaquig | $48 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $38 | 2 payments
|
| CSL Behring | Hizentra | $35 | 2 payments
|
| Merck Sharp & Dohme | None | $23 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $16 | 1 payment
|
| Genzyme | Dupixent | $14 | 1 payment
|
2022: $4,627
| AstraZeneca Pharmaceuticals LP | Fasenra | $4,018 | 10 payments
|
| OptiNose US | Xhance | $113 | 4 payments
|
| Pfizer | Cibinqo | $76 | 3 payments
|
| Jubilant HollisterStier | None | $71 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $60 | 2 payments
|
| Abbvie | Rinvoq | $50 | 3 payments
|
| BioCryst US Sales Co. | Orladeyo | $34 | 2 payments
|
| Amgen | Tezspire | $32 | 2 payments
|
| Incyte | Opzelura | $30 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $29 | 1 payment
|
| Aimmune Therapeutics | Palforzia | $26 | 1 payment
|
| Grifols USA | Xembify | $24 | 1 payment
|
| Pharming Healthcare | Ruconest | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $17 | 1 payment
|
| Covis Pharma GmBH | Alvesco | $15 | 1 payment
|
| Seqirus USA | Flucelvax Quadrivalent | $12 | 1 payment
|
2021: $4,252
| AstraZeneca Pharmaceuticals LP | Fasenra | $3,657 | 8 payments
|
| Genzyme | Dupixent | $141 | 3 payments
|
| Octapharma USA | Cutaquig | $99 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $97 | 4 payments
|
| kaleo | Auvi-Q | $79 | 4 payments
|
| CSL Behring | Haegarda | $44 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 2 payments
|
| Pfizer | Eucrisa | $32 | 2 payments
|
| Pharming Healthcare | Ruconest | $15 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $14 | 1 payment
|
| AbbVie | None | $14 | 1 payment
|
| Optinose US | Xhance | $12 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $12 | 1 payment
|
2020: $8,971
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $3,723 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $2,680 | 9 payments
|
| Pfizer | Eucrisa | $1,757 | 3 payments
|
| Boehringer Ingelheim International GmbH | Spiriva Respimat | $452 | 1 payment
|
| Octapharma USA | Cutaquig | $127 | 2 payments
|
| OptiNose US | Xhance | $63 | 3 payments
|
| CSL Behring | Haegarda | $60 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $23 | 1 payment
|
| Genentech USA | Xolair | $22 | 1 payment
|
| Teva Pharmaceuticals USA | Proair Digihaler | $21 | 1 payment
|
| BioCryst Pharmaceuticals | Orladeyo | $16 | 1 payment
|
| kaleo | Auvi-Q | $15 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $12 | 1 payment
|
2019: $33,029
| AstraZeneca Pharmaceuticals LP | Fasenra | $27,487 | 33 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $2,103 | 8 payments
|
| AstraZeneca UK | None | $1,692 | 1 payment
|
| Pfizer | Eucrisa | $603 | 7 payments
|
| Octapharma USA | Cutaquig | $503 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $218 | 3 payments
|
| Shire North American Group | Takhzyro | $145 | 7 payments
|
| OptiNose US | Xhance | $127 | 5 payments
|
| Greer Laboratories | Oralair | $51 | 3 payments
|
| Teva Pharmaceuticals USA | Cinqair | $38 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $27 | 2 payments
|
| Hospira | Panzyga | $18 | 1 payment
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| AstraZeneca Pharmaceuticals LP · A Randomized, Placebo-Controlled, Double-Blind, Multicenter, 12 Week, 3-Way, Partial-Replicate Crossover Pharmacodynamic Study To Assess the Equivalence of Budesonide and Albuterol (Bda) Delivered By Mdi Hfo Compared With Bda Delivered By Mdi Hfa in Participants With Asthma · 2025 | Their institution | $255,591 |
| AstraZeneca Pharmaceuticals LP · A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 To 52 Week Variable Length Study To Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler · 2023 | Their institution | $87,500 |
| Amphastar Pharmaceuticals, Inc. · Pharmacodynamic (Pd) Bronchodilatation Bioequivalence (Be) Study of Albuterol Sulfate Hfa Mdi 90 Mcg/Inhalation in Asthma Patients · 2019 | Their institution | $49,662 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study To Assess the Efficacy, Safety, and Tolerability of Subcutaneous Amlitelimab in Adult Participants With Moderate-To-Severe Asthma · 2023 | Their institution | $48,215 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma · 2024 | Their institution | $44,499 |
| Novartis Pharmaceuticals Corporation · A 12-Week, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Study To Assess the Efficacy and Safety of Csj117, When Added To Existing Asthma Therapy in Patients ? 18 Years of Age With Severe Uncontrolled Asthma. · 2021 | Their institution | $39,159 |
| SANOFI US SERVICES INC. · A Long-Term Extension Study To Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate-To-Severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study · 2024 | Their institution | $37,604 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma · 2025 | Their institution | $36,937 |
| AstraZeneca Pharmaceuticals LP · A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 To 52 Week Variable Length Study To Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler · 2022 | Their institution | $35,987 |
| AstraZeneca Pharmaceuticals LP · A Phase II, Randomized, Double-Blind, Single-Dose, Placebo-Controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study To Compare the Bronchodilatory Effect and Safety of Pt007 As Mdi To Placebo Mdi and Open-Label Ventolin Evohaler in Adult Participants With Asthma Mitchell · 2025 | Their institution | $35,224 |
| Teva Pharmaceuticals USA, Inc. · A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study To Assess the Safety, Efficacy and Pharmacodynamics of Tev 53275 Administered Subcutaneously in Adult Patients With Persistent Eosinophilic Asthma · 2022 | Their institution | $30,693 |
| AstraZeneca Pharmaceuticals LP · A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 To 52 Week Variable Length Study To Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler · 2025 | Their institution | $30,405 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study To Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 Mcg, To Flovent Hfa 110 Mcg, in Adult Subjects With Asthma · 2019 | Their institution | $28,310 |
| AstraZeneca Pharmaceuticals LP · A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 To 52 Week Variable Length Study To Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler · 2024 | Their institution | $26,922 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Proof-of-Concept (Poc) Study To Assess the Efficacy, Safety, and Tolerability of Sar440340 and the Coadministration of Sar440340 · 2019 | Their institution | $26,512 |
| SANOFI US SERVICES INC. · A Long-Term Extension Study To Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate-To-Severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study · 2025 | Their institution | $24,858 |
| Amphastar Pharmaceuticals, Inc. · Phamacodynamic (Pd) Bronchodilatation Bioequivalence (Be) Study of Albuterol Sulfate Hfa Mdi 90 Mcg/Inhalation in Asthma Patients · 2020 | Their institution | $24,394 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study To Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 Mcg, To Flovent Hfa 110 Mcg, in Adult Subjects With Asthma · 2021 | Their institution | $23,341 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Multiple-Dose, Blinded, Placebo-Controlled, Parallel-Design, Multiple-Center, Clinical Study To Evaluate the Therapeutic Equivalence of Fluticasone Propionate and Salmeterol Inhalation Powder, 100 Mcg/50 Mcg To Advair Diskus 100/50 (Fluticasone Propionate/Salmeterol) Inhalation Powder, in Subjects With Asthma · 2019 | Their institution | $22,600 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, 2-Part Study To Evaluate the Efficacy and Safety of Dupilumab in Patients With Uncontrolled, Chronic Rhinosinusitis Without Nasal Polyposis (Crssnp) · 2023 | Their institution | $22,440 |
| Teva Pharmaceuticals USA, Inc. · A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study To Assess the Safety, Efficacy and Pharmacodynamics of Tev 53275 Administered Subcutaneously in Adult Patients With Persistent Eosinophilic Asthma · 2021 | Their institution | $21,610 |
| AstraZeneca Pharmaceuticals LP · A Randomized, Placebo-Controlled, Double-Blind, Multicenter, 12 Week, 3-Way, Partial-Replicate Crossover Pharmacodynamic Study To Assess the Equivalence of Budesonide and Albuterol (Bda) Delivered By Mdi Hfo Compared With Bda Delivered By Mdi Hfa in Participants With Asthma · 2024 | Their institution | $20,187 |
| Novartis Pharmaceuticals Corporation · A Two Treatment Epoch Randomized Placebo Controlled Multi Centered Parallel Group Study To Assess the Safety of Qaw039 When Added To Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma · 2019 | Their institution | $19,864 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study To Assess the Efficacy, Safety, and Tolerability of Subcutaneous Amlitelimab in Adult Participants With Moderate-To-Severe Asthma · 2024 | Their institution | $18,745 |
| AstraZeneca Pharmaceuticals LP · A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of Pt001 To Placebo and Open-Label Spiriva Respimat in Subjects With Persistent Asthma · 2019 | Their institution | $17,650 |
| Regeneron Pharmaceuticals, Inc. · Aim4: Next Step - Asthma Uncontrolled With Ics in Medium Dose (Gina 4): Next Step; Efficacy of Dupilumab Added To Medium Dose Ics/Laba in Comparison To Ics Dose Escalation To High Dose Ics/Laba in Patients With Uncontrolled Asthma · 2025 | Their institution | $16,724 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study To Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 Mcg, To Flovent Hfa 110 Mcg, in Adult Subjects With Asthma · 2020 | Their institution | $14,252 |
| Novartis Pharmaceuticals Corporation · A 12-Week, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Study To Assess the Efficacy and Safety of Csj117, When Added To Existing Asthma Therapy in Patients ? 18 Years of Age With Severe Uncontrolled Asthma. · 2020 | Their institution | $13,422 |
| Teva Pharmaceuticals USA, Inc. · A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Tev-48574 in Adults With T2-Low/Non-T2 Severe Uncontrolled Asthma · 2022 | Their institution | $13,339 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, 2-Part Study To Evaluate the Efficacy and Safety of Dupilumab in Patients With Uncontrolled, Chronic Rhinosinusitis Without Nasal Polyposis (Crssnp) · 2022 | Their institution | $12,240 |
| Novartis Pharmaceuticals Corporation · A 12-Week, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Study To Assess the Efficacy and Safety of Csj117, When Added To Existing Asthma Therapy in Patients ? 18 Years of Age With Severe Uncontrolled Asthma. · 2022 | Their institution | $12,170 |
| Roche Products Limited · Open Label Extension Study of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps · 2019 | Their institution | $12,042 |
| Novartis Pharmaceuticals Corporation · A 52 Week Multicenter Randomized Double Blind Placebocontrolled Study To Assess the Efficacy and Safety of Qaw039 When Added To Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma · 2019 | Their institution | $11,948 |
| AstraZeneca Pharmaceuticals LP · Study To Assess the Efficacy and Safety of Pt010 Relative To Pt003 and Pt009 in Subjects With Moderate To Very Severe Copd (Ethos) · 2019 | Their institution | $11,017 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study To Assess the Efficacy, Safety, and Tolerability of Subcutaneous Amlitelimab in Adult Participants With Moderate-To-Severe Asthma · 2022 | Their institution | $10,400 |
| Teva Pharmaceuticals USA, Inc. · A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma · 2019 | Their institution | $9,325 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Multiple-Dose, Blinded, Placebo-Controlled, Parallel-Design, Multiple-Center, Clinical Study To Evaluate the Therapeutic Equivalence of Fluticasone Propionate and Salmeterol Inhalation Powder, 100 Mcg/50 Mcg To Advair Diskus 100/50 (Fluticasone Propionate/Salmeterol) Inhalation Powder, in Subjects With Asthma · 2020 | Their institution | $9,280 |
| AstraZeneca AB · A Study of the Safety and Effectiveness of Benralizumab To Treat Patients With Severe Uncontrolled Asthma. · 2020 | Their institution | $8,791 |
| AstraZeneca AB · A Study of the Safety and Effectiveness of Benralizumab To Treat Patients With Severe Uncontrolled Asthma. · 2019 | Their institution | $7,807 |
| Roche Products Limited · Ph3 Randomized Multicenter Double Blind Placebo Controlled Trial of Omalizumab for Nasal Polyps · 2019 | Their institution | $7,798 |
| Amphastar Pharmaceuticals, Inc. · Pharmacodynamic (Pd) Bronchodilatation Bioequivalence (Be) Study of Albuterol Sulfate Hfa Mdi 90 Mcg/Inhalation in Asthma Patients · 2021 | Their institution | $7,756 |
| Teva Pharmaceuticals USA, Inc. · A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Tev-48574 in Adults With T2-Low/Non-T2 Severe Uncontrolled Asthma · 2021 | Their institution | $7,478 |
| Mylan Specialty L.P. · A Phase 4, Randomized, Double-Blind, Double-Dummy, Parallel Group Study Comparing Improvements in Lung Function in Adults With Severe To Very Severe Chronic Obstructive Pulmonary Disease and Suboptimal Inspiratory Flow Rate Following Once-Daily Treatment Over 12 Weeks With Either Revefenacin Inhalation Solution Delivered Via Standard Jet Nebulizer Or Tiotropium Delivered Via A Dry Powder Inhaler (Spiriva Handihaler) · 2023 | Their institution | $7,154 |
| Novartis Pharmaceuticals Corporation · A Two Treatment Epoch Randomized Placebo Controlled Multi Centered Parallel Group Study To Assess the Safety of Qaw039 When Added To Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma · 2020 | Their institution | $5,515 |
| AstraZeneca Pharmaceuticals LP · A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of Pt001 To Placebo and Open-Label Spiriva Respimat in Subjects With Persistent Asthma · 2020 | Their institution | $5,405 |
| Novartis Pharmaceuticals Corporation · A 12 Week Multicenter Randomized Double Blind Placebo Controlled Study To Assess the Efficacy and Safety of Qaw039 When Added To Standard of Care Asthma Therapy in Patients With Uncontrolled Asthma · 2019 | Their institution | $4,506 |
| Optinose US, Inc. · A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 G of Opn-375 Twice A Day Bid in Subjects With Chronic Sinusitis Without the Presence of Nasal Polyps. Opn-Flu-Cs-3206. · 2019 | Their institution | $4,500 |
| Roche Products Limited · Open Label Extension Study of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps · 2020 | Their institution | $3,872 |
| SANOFI US SERVICES INC. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study To Assess the Efficacy, Safety, and Tolerability of Subcutaneous Amlitelimab in Adult Participants With Moderate-To-Severe Asthma · 2025 | Their institution | $2,625 |
| Teva Pharmaceuticals USA, Inc. · Connected Electronic Inhalers Asthma Control Trial 1 ("Connect 1"), A 12-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison, Feasibility Study To Evaluate the Effectiveness of the Albuterol Emdpi Digital System, To Optimize Outcomes in Patients at Least 13 Years of Age Or Older With Asthma · 2020 | Their institution | $1,760 |
| Novartis Pharmaceuticals Corporation · A Multi Center Randomized 52 Weeks Treatment Double Blind Triple Dummy Study To Assess the Efficacy and Safety of Qmf149 Compared With Mometasone Furoate and Salmeterol Fluticasone · 2019 | Their institution | $1,360 |
| Optinose US, Inc. · A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 G of Opn-375 Twice A Day (Bid) in Subjects With Chronic Sinusitis Without the Presence of Nasal Polyps. Opn-Flu-Cs-3206. · 2021 | Their institution | $1,200 |
| Novartis Pharmaceuticals Corporation · A 12 Week Multicenter Randomized Double Blind Placebo Controlled Study To Assess the Efficacy and Safety of Qaw039 When Added To Standard of Care Asthma Therapy in Patients With Uncontrolled Asthma · 2020 | Their institution | $1,088 |
| Novartis Pharmaceuticals Corporation · A 12-Week, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Study To Assess the Efficacy and Safety of Csj117, When Added To Existing Asthma Therapy in Patients ? 18 Years of Age With Severe Uncontrolled Asthma. · 2023 | Their institution | $900 |
| Mylan Specialty L.P. · A Phase 4, Randomized, Double-Blind, Double-Dummy, Parallel?Group Study Comparing Improvements in Lung Function in Adults With Severe To Very Severe Chronic Obstructive Pulmonary Disease and Suboptimal Inspiratory Flow Rate Following Once-Daily Treatment Over 12 Weeks With Either Revefenacin Inhalation Solution Delivered Via Standard Jet Nebulizer Or Tiotropium Delivered Via A Dry Powder Inhaler (Spiriva Handihaler) · 2024 | Their institution | $795 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma · 2023 | Their institution | $409 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1508839457
- Licence
- CA C034965
- Trained
- University of North Carolina at Chapel Hill School of Medicine, 1968 · 58 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00C349650
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 4628 Georgetown Pl, Stockton, CA, 95207
- NPI first listed
- 2006-02-10
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.